I guess part of the problem is we've moved away from MYC and cancer at least directly and now targeting ASO's. A good cancer treatment or development In that field will always generate huge interest as it did when we first worked with omomyc. Unfortunately even if we are successful with ASO's it might still be difficult to generate any excitement with lab results, unless we can actually get a new deal with the data. Even then a deal with anything less than 2-3 million up front would probably still disappoint as too much history with those deals never working out to much. Hard work ahead.
PYC Price at posting:
2.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)